European Commission
Cancer Mission Innovation Action – HORIZON-MISS-2026-02-CANCER-05
17:00 Brussels time
Last verified:
The Cancer Mission Innovation Action, HORIZON-MISS-2026-02-CANCER-05 offers approximately €7 million in Horizon Europe funding for applied cancer research projects led by multi-country consortia. This one-off call funds innovation actions that translate cancer research into clinical or public-health impact, with a focus on cross-border collaboration. Applicants must form consortia of at least 3 entities across 3 EU member states or associated countries.
Details
| Funder | European Commission |
| Budget | Around €7M |
| Deadline | 15 September 2026 |
| Consortium | Required — minimum 3 entities from 3 EU member states |
| Application | Single stage |
| Frequency | One-off |
Eligibility & scope
Horizon Europe Innovation Action under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €7M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.
Who Should Apply
- •Applied cancer researchers and clinicians ready to lead or co-lead a consortium
- •Research institutions, hospital networks, and industry partners in EU member states or associated countries
- •Teams with established multi-country partnerships or strong capacity to build them quickly
- •Projects with a clear pathway to clinical implementation or health-system adoption
Key Dates
- •Deadline: 15 September 2026, 17:00 Brussels time
- •Single-stage application and evaluation
- •Project duration: typically 4-5 years in Horizon Europe Innovation Actions
Tips for Applicants
- ✓Consortium composition is gate-keeping, validate early that partners are eligible and committed before drafting the proposal.
- ✓Horizon Europe reviewers weight feasibility and risk mitigation heavily; avoid over-ambitious timelines across three+ countries.
- ✓The innovation angle must be clear: detail the end-user (clinicians, patients, industry) and the adoption or dissemination plan, not just the science.
Frequently Asked Questions
How much does the Cancer Mission Innovation Action grant provide?
Approximately €7 million in total Horizon Europe funding for the single indicative grant in this call.
Who can apply for the Cancer Mission Innovation Action?
Consortia of at least 3 eligible entities from 3 different EU member states or associated countries; institutions, hospitals, and industry partners are eligible.
What is the deadline for the Cancer Mission Innovation Action?
15 September 2026 at 17:00 Brussels time.
Is this a recurring call?
No, this is a one-off call; there is no announced successor round.
Related on Grantsby
- European Commission writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from European Commission
Marie Sklodowska-Curie Actions (MSCA) Postdoctoral Fellowships 2026
Deadline: 9 Sept 2026Marie Skłodowska-Curie Actions Postdoctoral Fellowships (MSCA-PF) 2026
Deadline: 9 Sept 2026HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships (HORIZON-TMA-MSCA-PF-EF)
Deadline: 9 Sept 2026HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships (HORIZON-TMA-MSCA-PF-GF)
Deadline: 9 Sept 2026Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Deadline: 15 Sept 2026€7M–€8M per grant
Browse Related
Could Cancer Mission Innovation Action – HORIZON-MISS-2026-02-CANCER-05 be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →